Erika Jones

Insider Reports History

Entity
Individual
Location
C/O Black Diamond Therapeutics, Inc., One Main Street, 10 Th Floor, Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erika Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. Officer Title: Vice President, Finance and Corporate Controller Common Stock 10.2K $27.7K $2.73 Feb 13, 2023 Direct
Black Diamond Therapeutics, Inc. Officer Title: Vice President, Finance and Corporate Controller Stock Option (Right to Buy) 100K Feb 14, 2024 Direct

Insider Reports Filed by Erika Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDTX Black Diamond Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 Officer Title: Vice President, Finance and Corporate Controller
BDTX Black Diamond Therapeutics, Inc. Feb 13, 2023 2 $0 4 Feb 15, 2023 Officer Title: Vice President, Finance and Corporate Controller
BDTX Black Diamond Therapeutics, Inc. Feb 15, 2022 2 $0 4 Feb 17, 2022 Officer Title: Vice President, Finance and Corporate Controller
BDTX Black Diamond Therapeutics, Inc. Nov 18, 2021 0 $0 3 Nov 29, 2021 Officer Title: Vice President, Finance and Corporate Controller